This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignees: Laboratorios Salvat, S.a., Chiesi Farmaceutici S.p.a.. Active years: 2005-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005-2008
Title: Dolors Balsa Lopez: Innovator in Pharmaceutical Chemistry
Introduction
Dolors Balsa Lopez is a prominent inventor based in Badalona, Spain. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of muscarinic receptor antagonists. With a total of 3 patents to her name, her work has the potential to impact various medical treatments.
Latest Patents
Her latest patents include innovative carbamate derivatives, specifically designed for use as muscarinic receptor antagonists. One notable invention is a carbamate of general formula (I), which features a range of substituents such as H, OH, NO, and various halogens. This compound is particularly effective in treating conditions like urinary incontinence, irritable bowel syndrome, and respiratory disorders, including chronic obstructive pulmonary disease and asthma. Another patent focuses on carbamates derived from arylalkylamines, which also serve as antagonists of the muscarinic receptor, further expanding the therapeutic applications of her research.
Career Highlights
Dolors has worked with notable companies in the pharmaceutical industry, including Laboratorios Salvat and Chiesi Farmaceutici. Her experience in these organizations has allowed her to refine her expertise and contribute to significant advancements in drug development.
Collaborations
Throughout her career, Dolors has collaborated with esteemed colleagues such as Carles Farrerons Gallemi and Juan Lorenzo Catena Ruiz. These partnerships have fostered a collaborative environment that enhances innovation and research in her field.
Conclusion
Dolors Balsa Lopez is a trailblazer in pharmaceutical chemistry, with a focus on developing effective treatments for various medical conditions. Her innovative patents and collaborations highlight her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
